Trial Condition(s):
Contraception, Male
Study to assess Norethisterone Enanthate (NET-EN) plus Testosterone Undecanoate (TU) for male contraception
Bayer Identifier:
90851
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
Please see attached Study Results Summary below.
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
40
Trial Dates
Phase
2
Could I receive a placebo?
No
Products
Norethisterone e./Testosterone u. (BAY86-5037)
Accepts Healthy Volunteers
N/A
Where to Participate
Locations
| Locations |
|---|
Trial Design
Norethisterone enanthate (NET-EN) plus Testosterone undecanoate (TU) for male contraception - a prospective, randomized, 4-arm parallel-group, controlled single-blind study
Trial Type:
Interventional
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
N/A
Primary Outcome
- Timeframe:
Secondary Outcome
- Timeframe:
Additional Information
Copyright © Bayer
Powered by
